Dhiraj Kumar

2.0k total citations
28 papers, 1.3k citations indexed

About

Dhiraj Kumar is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Dhiraj Kumar has authored 28 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Dhiraj Kumar's work include Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (6 papers) and Bone and Dental Protein Studies (3 papers). Dhiraj Kumar is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer Cells and Metastasis (6 papers) and Bone and Dental Protein Studies (3 papers). Dhiraj Kumar collaborates with scholars based in United States, India and China. Dhiraj Kumar's co-authors include Gopal C. Kundu, Amit Singh Yadav, Ramesh Butti, Vinoth Prasanna Gunasekaran, Mahadeo Gorain, Sumit Das, Santosh Kumar, Gautam Kundu, Poonam R. Pandey and Totakura V. S. Kumar and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dhiraj Kumar

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Dhiraj Kumar

Since Specialization

Citations

This map shows the geographic impact of Dhiraj Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhiraj Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhiraj Kumar more than expected).

Fields of papers citing papers by Dhiraj Kumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhiraj Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhiraj Kumar. The network helps show where Dhiraj Kumar may publish in the future.

Co-authorship network of co-authors of Dhiraj Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Dhiraj Kumar. A scholar is included among the top collaborators of Dhiraj Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dhiraj Kumar. Dhiraj Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brd7 loss reawakens dormant metastasis initiating cells in lung by forging an immunosuppressive niche 2025 ·Nature Communications ·Jayanta Mondal, Junfeng Zhang, (unknown), Shunping Li, Dhiraj Kumar, Jason T. Huse, Filippo G. Giancotti	4
2	STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response 2024 ·Leukemia ·Bhakti Patel, Yifan Zhou, (unknown), Feiyang Ma, Malgorzata Anna Zal, Dhiraj Kumar, Yusra B. Medik, Laura M. Kahn, (unknown), Elizabeth M. Park, Sarah Schneider, Ximing Tang, Maria Gabriela Raso, Collene Jeter, Tomasz Żal, Karen Clise-Dwyer, Khandan Keyomarsi, Filippo G. Giancotti, Simona Colla, Stephanie S. Watowich	2
3	Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington’s disease 2023 ·Scientific Reports ·(unknown), Dhiraj Kumar, (unknown), (unknown), (unknown), Dan Lindholm, Merja H. Voutilainen	5
4	Antiproliferative and Apoptotic Potential of Methotrexate Lipid Nanoparticles in A Murine Breast Cancer Model 2022 ·Nanomedicine ·(unknown), Ananya Banerjee, S Anupriya, (unknown), Dhiraj Kumar, Ramesh Butti, Mahadeo Gorain, (unknown), Gopal C. Kundu, Supriya Shidhaye, Srinivas Patnaik	5
5	RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics 2022 ·Molecular Cancer ·Poonam R. Pandey, Ken H. Young, Dhiraj Kumar, Neeraj Jain	66
6	Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway 2022 ·Cancer Cell International ·(unknown), Amit Singh Yadav, (unknown), Totakura V. S. Kumar, Anuradha Bulbule, (unknown), Dhiraj Kumar, (unknown), Srikanth Rapole, Gopal C. Kundu	99
7	750 Malat1 lncRNA controls metastatic reactivation of dormant breast cancer by immune evasion 2020 ·SHILAP Revista de lepidopterología ·Dhiraj Kumar, Sreeharsha Gurrapu, Hyun Ho Han, Yan Wang, Seong‐Yeon Bae, Hong Chen, Chang‐Jiun Wu, Filippo G. Giancotti	2
8	Non-coding RNAs as potential therapeutic targets in breast cancer 2019 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·(unknown), Amit Singh Yadav, Dhiraj Kumar, (unknown), Gopal C. Kundu	67
9	Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway 2018 ·BMC Cancer ·Dhiraj Kumar, Saikat Haldar, Mahadeo Gorain, Santosh Kumar, Fayaj A. Mulani, Amit Singh Yadav, Lucio Miele, Hirekodathakallu V. Thulasiram, Gopal C. Kundu	56
10	Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges 2018 ·Molecular Cancer ·Ramesh Butti, Sumit Das, Vinoth Prasanna Gunasekaran, Amit Singh Yadav, Dhiraj Kumar, Gopal C. Kundu	276
11	Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma 2017 ·Molecular Cancer ·Dhiraj Kumar, Mahadeo Gorain, Gautam Kundu, Gopal C. Kundu	58
12	Ascochlorin Enhances the Sensitivity of Doxorubicin Leading to the Reversal of Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma 2016 ·Molecular Cancer Therapeutics ·Xiaoyun Dai, Kwang Seok Ahn, Ling Zhi Wang, Chulwon Kim, (unknown), Frank Arfuso, Jae‐Young Um, Alan Prem Kumar, Young‐Chae Chang, Dhiraj Kumar, Gopal C. Kundu, Junji Magae, Boon Cher Goh, Kam M. Hui, Gautam Sethi	82
13	Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis 2016 ·Journal of Investigative Dermatology ·Dhiraj Kumar, Santosh Kumar, Mahadeo Gorain, (unknown), (unknown), (unknown), Totakura V. S. Kumar, (unknown), Hirekodathakallu V. Thulasiram, Gopal C. Kundu	62
14	Facile synthesis of autophagonizer and evaluation of its activity to induce autophagic cell death in apoptosis-defective cell line 2016 ·Bioorganic & Medicinal Chemistry Letters ·Jennifer Nguyen, Luxi Chen, Dhiraj Kumar, Jiyong Lee	1
15	The potential of class 3 semaphorins as both targets and therapeutics in cancer 2014 ·Expert Opinion on Therapeutic Targets ·(unknown), Dhiraj Kumar, (unknown), Goutam Chakraborty, Santosh Kumar, Gopal C. Kundu	10
16	Functional Characterization of Stromal Osteopontin in Melanoma Progression and Metastasis 2013 ·PLoS ONE ·Santosh Kumar, Priyanka Sharma, Dhiraj Kumar, Goutam Chakraborty, Mahadeo Gorain, Gopal C. Kundu	34
17	Novel Mps1 kinase inhibitors: From purine to pyrrolopyrimidine and quinazoline leads 2013 ·Bioorganic & Medicinal Chemistry Letters ·Matthew G. Bursavich, (unknown), Mark D. Shenderovich, Kraig M. Yager, Daniel Cimbora, Brandi L. Williams, Dhiraj Kumar	13
18	Andrographolide Inhibits Osteopontin Expression and Breast Tumor Growth Through Down Regulation of PI3 Kinase/Akt Signaling Pathway 2012 ·Current Molecular Medicine ·Santosh Kumar, (unknown), Priyanka Sharma, Dhiraj Kumar, Santosh K. Dasari, Vedavati G. Puranik, Hirekodathakallu V. Thulasiram, Gautam Kundu	54
19	Osteopontin: a potentially important therapeutic target in cancer 2011 ·Expert Opinion on Therapeutic Targets ·Mansoor Ahmed, Reeti Behera, Goutam Chakraborty, Shalini Jain, Vinit Kumar, (unknown), Anuradha Bulbule, Smita Kale, Santosh Kumar, (unknown), Remya Raja, (unknown), (unknown), Gowrishankar Soundararajan, Dhiraj Kumar, D Thorat, (unknown), (unknown), (unknown), Gopal C. Kundu	68
20	Abstract #LB-204: MPI-0479605: A novel small molecule inhibitor of the mitotic kinase TTK with anti-tumor activity in pre-clinical models 2009 ·Cancer Research ·Brandi L. Williams, Daniel Cimbora, Vijay Baichwal, Damon I. Papac, (unknown), J. Adam Willardsen, Dhiraj Kumar	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact